Arab Board Dermatology Part 1 common mistakes
Arab Board Dermatology Part 1 · Understand the traps and how to avoid them.
When shown a histology description, committing to a single diagnosis before systematically checking the pattern (lichenoid vs spongiotic vs psoriasiform vs interface vs nodular), then forcing the remaining features to fit it.
Candidates memorise disease-specific 'buzzword' features and pattern recognition shortcuts from textbooks instead of building a disciplined stepwise reading approach; under time pressure the first plausible diagnosis anchors all subsequent reasoning.
What to do instead
Practise a fixed algorithm for every dermatopathology stem: identify the primary reaction pattern, then level of the infiltrate, then the dominant cell type, then secondary change (parakeratosis, acantholysis, mucin). Only after listing the pattern-appropriate differential should you select an answer, and reject any option that violates the pattern even if it matches a memorised keyword.
Treating drug eruption morphology as diagnostic of the culprit drug, e.g., answering that a morbilliform rash is 'most likely' caused by the specific antibiotic named in the vignette rather than recognising that morbilliform eruptions are class-nonspecific.
Vignettes deliberately include a plausible recent drug to tempt pattern-matching; candidates confuse temporal association with causal specificity and do not distinguish eruption patterns that are drug-class-specific (e.g., DRESS, AGEP, fixed drug eruption) from those that are not.
What to do instead
Learn which reaction patterns carry drug-class specificity and which do not. For morbilliform and urticarial eruptions, answer based on timing and most-frequent-class epidemiology, not the named drug. For DRESS/AGEP/SJS-TEN, memorise the small set of high-risk classes and the latency windows, and use latency as the discriminator.
Classifying a contact dermatitis as irritant versus allergic based on the appearance of the rash alone, without using exposure history, distribution, latency, and patch test logic.
Both produce erythematous, vesicular, or lichenified plaques, and candidates over-rely on morphology; they also forget that irritant reactions can be delayed and that allergen identification requires patch testing, not history alone.
What to do instead
Build a comparison table in memory along four axes: latency (irritant immediate to hours, allergic 24–72 h on re-exposure), distribution (irritant at sites of maximal exposure including sharp cut-offs, allergic can spread), dose-response (irritant yes, allergic no), and confirmatory test (patch test for allergic). Answer questions by matching the stem to these axes rather than to the visual description.
Misassigning blistering diseases by the level of the split, e.g., calling pemphigus vulgaris a subepidermal blister or labelling bullous pemphigoid intraepidermal, because the candidate memorised 'pemphigus = blistering' without anchoring each disease to its target antigen and ultrastructural level.
Autoimmune bullous diseases are taught as a list of names and antibodies; without a spatial framework the details collapse into each other, and immunofluorescence patterns are memorised as isolated facts rather than derived from antigen location.
What to do instead
Anchor every bullous disease to a two-column map: antigen (desmoglein 1/3, BP180/BP230, type VII collagen, laminin-332, plakins) and level (intraepidermal vs subepidermal). Then derive DIF (intercellular vs linear basement membrane), salt-split skin side (roof vs floor), and clinical correlate from that map. Reconstruct the whole table from antigens each time you revise.
Choosing the next management step for a pigmented lesion or skin cancer based on the suspected diagnosis rather than on the diagnostic uncertainty, e.g., recommending excision with a fixed margin before a tissue diagnosis exists, or omitting the biopsy when dermoscopy is 'reassuring'.
Candidates conflate staging margins with diagnostic excision and are seduced by dermoscopic pattern recognition; exam stems often include a reassuring-sounding dermoscopy description to test whether the candidate still biopsies an atypical lesion.
What to do instead
Apply a rule: any lesion where melanoma cannot be excluded gets a diagnostic biopsy (excisional where feasible, narrow margins, no destructive techniques). Reserve wide margins for after histopathology confirms diagnosis and gives Bresenham thickness. For dermoscopy stems, ask whether the described pattern is genuinely benign-specific; if not, the answer is biopsy.
Answering photodermatology questions by pattern-matching 'sun-exposed distribution' to a single diagnosis (usually lupus) and ignoring the action spectrum, timing of onset, and whether the eruption is provoked by a specific wavelength or by a systemic agent.
Sun-exposed distribution is shared by many conditions (photosensitivity, photoaggravated dermatoses, airborne contact, rosacea, dermatomyositis), and candidates do not separate true photosensitivity from photoaggravation or from phototoxicity/photocontact allergy.
What to do instead
For every photodermatology stem, extract three variables: latency after exposure (minutes to hours vs days), action spectrum (UVA vs UVB as implied by history or testing), and distribution (sharp cut-offs at clothing, sparing of covered skin, involvement of face). Then place the diagnosis in the photodermatosis vs photoaggravated vs phototoxic/photocontact categories before selecting.
Confusing colonisation with infection in cutaneous microbiology, e.g., treating a positive swab for Staphylococcus aureus in an atopic patient as proof of infection, or dismissing a coagulase-negative staphylococcus as a contaminant in a patient with a prosthetic device.
Candidates treat laboratory results as binary rather than as requiring clinical correlation; they also do not adjust interpretation for host factors such as devices, immunosuppression, and skin barrier integrity.
What to do instead
For every microbiology stem, state the host context first (immunocompetence, device, barrier defect, prior antibiotics) and then interpret the organism against that context. Learn the small set of situations where normally commensal organisms are pathogenic (prosthetic material, neutropenia, central lines, bite wounds) and the situations where a classic pathogen is a coloniser.
In paediatric and genodermatology stems, applying adult disease definitions to children, e.g., diagnosing psoriasis or lichen planus in an infant without considering the paediatric-specific differential, or missing a syndromic association because only the skin finding was addressed.
Training is adult-weighted and candidates under-practise paediatric morphology; genodermatoses are memorised as isolated skin signs rather than as multisystem syndromes with inheritance patterns.
What to do instead
For paediatric stems, run a mandatory syndromic screen: ask whether the skin finding is isolated or part of a named syndrome, and list the associated systems (eyes, teeth, nails, hair, sweating, neurodevelopment) before committing. Revise genodermatoses in a three-column format: inheritance, skin finding, associated systemic features, and test yourself by generating the syndrome from the skin finding alone.
Selecting a systemic therapy for a skin disease without checking the pre-treatment screening, monitoring, or absolute contraindication that the question is actually testing, e.g., starting methotrexate without discussing pregnancy or liver risk, or isotretinoin without a pregnancy programme.
Candidates focus on efficacy and mechanism, and treat safety monitoring as background knowledge; exam questions often make the correct answer a safety step rather than the drug itself.
What to do instead
For each major systemic agent (methotrexate, cyclosporine, azathioprine, isotretinoin, biologics, dapsone, colchicine, hydroxychloroquine), write a one-page card with baseline tests, monitoring interval, absolute contraindications, and the key interaction or idiosyncratic reaction. When a stem asks 'next step', scan the options for the safety step before the efficacy step.
Misclassifying vasculitis by vessel size and ignoring the direct immunofluorescence and systemic workup, e.g., labelling a leukocytoclastic vasculitis as a single disease rather than as a reaction pattern requiring a search for cause, or missing a small-vessel vs medium-vessel distinction.
Vasculitis nomenclature is confusing and candidates memorise eponyms without the size-based framework; they also forget that cutaneous LCV is a pattern with many causes, not a diagnosis.
What to do instead
Rebuild vasculitis on a vessel-size scaffold (small: LCV/IgA/HSP/urticarial; medium: polyarteritis nodosa; large: giant cell). For any LCV stem, answer in two stages: describe the pattern, then state the mandatory evaluation (DIF, urinalysis, renal function, hepatitis and other cause-directed tests). Never select a single idiopathic diagnosis for LCV unless the stem excludes secondary causes.